Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Trumenba in Healthy Infants
NCT00798304Phase 2Terminated
- Sponsor
- Pfizer
- Start
- Jan 2009
- Primary completion
- Jun 2009
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of meningococcal group B vaccine in meningococcal meningitis, sponsored by Pfizer. Started Jan 2009; status: terminated.
02
Drugs
meningococcal group B vaccine
03
Conditions
meningococcal meningitis
Beyond the preview
Go deeper on NCT00798304.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00798304.